| Unbound MEDLINE results for: | Bookmark this site | | Articles related to 12377641 [Unique ID], provided by the PubMed system | |
| |
|
| | 1 - 10 of 1465 journal articles in the PubMed database | Email to a friend | | |
| Rosell R, Gatzemeier U, Betticher DC, et al.
Phase III randomised trial comparing paclitaxel/carboplatin with paclitaxel/cisplatin in patients with advanced non-small-cell lung cancer: a cooperative multinational trial. [Clinical Trial, Clinical Trial, Phase III, Journal Article, Multicenter Study, Randomized Controlled Trial]
Ann Oncol 2002 Oct; 13(10):1539-49.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Comella P, Frasci G, De Cataldis G, et al.
Cisplatin/carboplatin + etoposide + vinorelbine in advanced non-small-cell lung cancer: a multicentre randomised trial. Gruppo Oncologico Campano. [Clinical Trial, Clinical Trial, Phase III, Journal Article, Multicenter Study, Randomized Controlled Trial]
Br J Cancer 1996 Dec; 74(11):1805-11.
Abstract | Full Citation | Find Related Articles | | Giaccone G, Splinter TA, Debruyne C, et al.
Randomized study of paclitaxel-cisplatin versus cisplatin-teniposide in patients with advanced non-small-cell lung cancer. The European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group. [Clinical Trial, Journal Article, Randomized Controlled Trial]
J Clin Oncol 1998 Jun; 16(6):2133-41.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Paccagnella A, Favaretto A, Oniga F, et al.
Cisplatin versus carboplatin in combination with mitomycin and vinblastine in advanced non small cell lung cancer. A multicenter, randomized phase III trial. [Clinical Trial, Clinical Trial, Phase III, Journal Article, Multicenter Study, Randomized Controlled Trial]
Lung Cancer 2004 Jan; 43(1):83-91.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Bonomi P, Kim K, Fairclough D, et al.
Comparison of survival and quality of life in advanced non-small-cell lung cancer patients treated with two dose levels of paclitaxel combined with cisplatin versus etoposide with cisplatin: results of an Eastern Cooperative Oncology Group trial. [Clinical Trial, Journal Article, Multicenter Study, Randomized Controlled Trial]
J Clin Oncol 2000 Feb; 18(3):623-31.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Paccagnella A, Oniga F, Bearz A, et al.
Adding gemcitabine to paclitaxel/carboplatin combination increases survival in advanced non-small-cell lung cancer: results of a phase II-III study. [Clinical Trial, Phase II, Clinical Trial, Phase III, Journal Article, Randomized Controlled Trial]
J Clin Oncol 2006 Feb 1; 24(4):681-7.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Langer C, Li S, Schiller J, et al.
Randomized phase II trial of paclitaxel plus carboplatin or gemcitabine plus cisplatin in Eastern Cooperative Oncology Group performance status 2 non-small-cell lung cancer patients: ECOG 1599. [Clinical Trial, Phase II, Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, N.I.H., Extramural]
J Clin Oncol 2007 Feb 1; 25(4):418-23.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Rodriguez J, Cortes J, Calvo E, et al.
Paclitaxel, cisplatin, and gemcitabine combination chemotherapy within a multidisciplinary therapeutic approach in metastatic nonsmall cell lung carcinoma. [Clinical Trial, Clinical Trial, Phase II, Journal Article]
Cancer 2000 Dec 15; 89(12):2622-9.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Laohavinij S, Maoleekoonpairoj S, Cheirsilpa A, et al.
Phase II study of paclitaxel and carboplatin for advanced non-small-cell lung cancer. [Clinical Trial, Clinical Trial, Phase II, Journal Article]
Lung Cancer 1999 Dec; 26(3):175-85.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |   |
|
| | Enter
www.unboundmedicine.com/medline
in your iPhone browser
or View our
Unbound MEDLINE
iPhone demo
Advertise on this site.
|
